Clinical Trial Update: Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A dose-finding Phase 1/2 clinical trial is evaluating Abraxane in combination with cisplatin for advanced nasopharyngeal carcinoma; the current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN